D. Zelinger

Most-cited papers

1. Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate.

   L. Moreland, Parks W. Pratt, M. Mayes, A. Postlethwaite +7 more

   1995Arthritis & Rheumatism123 citations

   Semantic Scholar

   Save

2. A multicenter retrospective experience of infliximab in Crohn's disease patients: infusion reaction rates and treatment persistency.

   A. Keshavarzian, L. Mayer, B. Salzberg, M. Garone +12 more

   2007Gastroenterology & hepatology26 citations

   Semantic Scholar

   Save

3. Early Serum Infliximab Trough Level, Clinical Disease Activity and CRP as Markers of Sustained Benefit of Infliximab Treatment in Crohnʼs Disease: A Post-hoc Analysis of the ACCENT1 Trial: 1226

   F. Cornillie, S. Hanauer, R. Diamond, Jun Wang +4 more

   201111 citations

   Semantic Scholar

   Save

4. Safety of readministration of abciximab; interim results of the ReoPro readministration registry (R3)

   J. Tcheng, D. Kereiakes, B. S. Georgo, G. Braden +4 more

   199811 citations

   Semantic Scholar

   Save

5. Clinical Pathologic Alterations Associated with Subcutaneous Administration of Recombinant Human Interleukin-4 to Cynomolgus Monkeys

   K. Gossett, T. Barbolt, J. Cornacoff, D. Zelinger +1 more

   1993Toxicologic pathology (Print)8 citations Open access

   Semantic Scholar

   Save

6. Reduction of animal use with improved procedure for acute tolerance assessment.

   R. Fabian, N. Fetrow, Yigal Greener, D. Zelinger +2 more

   1993Regulatory toxicology and pharmacology : RTP5 citations

   Semantic Scholar

   Save

7. Costs and effects in therapy for acute coronary syndromes : The case of abciximab in high-risk patients undergoing percutaneous transluminal coronary angioplasty in the EPIC study : Use of GP IIb/IIIa inhibitors in coronary syndromes: State of the Art

   B. van Hout, L. Bowman, D. Zelinger, M. Simoons

   19982 citations

   Semantic Scholar

   Save

8. Costs and effects in therapy for acute coronary syndromes: the case of abciximab in high-risk patients undergoing percutaneous transluminal coronary angioplasty in the EPIC study. Evaluation of 7E3 for the Prevention of Ischemic Complications.

   B. van Hout, L. Bowman, D. Zelinger, M. Simoons

   1998European Heart Journal1 citations

   Semantic Scholar

   Save

9. Chronic (1-year) safety evaluation of ipazilide fumarate, an antiarrhythmic agent, administered orally to rats.

   Yigal Greener, T. Barbolt, D. Zelinger, K. Gossett

   1993Fundamental and Applied Toxicology1 citations

   Semantic Scholar

   Save

10. Subchronic oral and intravenous (i.v.) safety evaluation and pharmacokinetics in rats and dogs of ipazilide fumarate (Win 54, 177-4), an antiarrhythmic agent.

    Yigal Greener, B. A. Mayes, Thomas A. Barbolt, J. P. Kimball +6 more

    1992Fundamental and Applied Toxicology1 citations

    Semantic Scholar

    Save

11. A Retrospective Review of Hepatosplenic T-Cell Lymphoma Reports Using the Dutch National Database of Pathology (PALGA)

    Michael O. Montgomery, Marit van Santen, R. Diamond, D. Zelinger +1 more

    20110 citations Open access

    Semantic Scholar

    Save

12. Costs and effects in therapy for acute coronary syndromes: the case of abciximab in high-risk patients undergoing percutaneous transluminal coronary angioplasty in the EPIC study. Evaluation of 7E3 for the Prevention of Ischemic Complications.

    B. van Hout, L. Bowman, D. Zelinger, M. Simoons

    1998American Heart Journal0 citations

    Semantic Scholar

    Save

13. Subchronic Oral and Intravenous (iv) Safety Evaluation and Pharmacokinetics in Rats and Dogs of Ipazilide Fumarate (Win 54, 177-4), an Antiarrhythmic Agent

    Y. Greener, B. A. Mayes, T. Barbolt, J. P. Kimball +6 more

    19920 citations

    Semantic Scholar

    Save

14. A comparison of procedures used to calculate intra-herd estimates of breeding value and producing ability.

    D. Zelinger

    19800 citations

    Semantic Scholar

    Save